0001012975-17-000719.txt : 20170926 0001012975-17-000719.hdr.sgml : 20170926 20170926183633 ACCESSION NUMBER: 0001012975-17-000719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170922 FILED AS OF DATE: 20170926 DATE AS OF CHANGE: 20170926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CZEREPAK ELIZABETH CENTRAL INDEX KEY: 0001263500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 171102944 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH CITY: RUTHERFORD STATE: NJ ZIP: 07070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Altimmune, Inc. CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2406541450 MAIL ADDRESS: STREET 1: 19 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATHENE, INC DATE OF NAME CHANGE: 20071016 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-09-22 0001326190 Altimmune, Inc. ALT 0001263500 CZEREPAK ELIZABETH C/O ALTIMMUNE, INC. 19 FIRSTFIELD ROAD, SUITE 200 GAITHERSBURG MD 20878 0 1 0 0 CFO and EVP Corp. Development Stock Options (option to buy) 2.48 2017-09-22 4 A 0 62500 0 A 2017-09-22 2027-09-22 Common Stock, par value $0.0001 62500 62500 D Stock Options (option to buy) 2.48 2017-09-22 4 A 0 62500 0 A 2019-03-31 2027-09-22 Common Stock, par value $0.0001 62500 62500 D The option becomes exercisable, if at all, on March 31, 2019, in three equal one-third increments if the average daily closing price of Altimmune, Inc.'s common stock on Nasdaq for 10 consecutive trading days between September 22, 2017 and December 31, 2018 is at or above one of three specified thresholds, respectively. /s/ Ori Solomon, Attorney in fact for Elizabeth Czerepak 2017-09-26